Financials
Reported figures only · latest: Q4 2025
CHF · IFRS
Revenue by quarter
Q2 24 Q2 25
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income12 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | CHF 3.6M | −CHF 70.4M |
|---|
| FY24 | CHF 27.3M | −CHF 50.9M |
|---|
| FY23 | CHF 14.8M | −CHF 54.2M |
|---|
| FY22 | CHF 3.9M | −CHF 70.8M |
|---|
| FY21 | CHF 0 | −CHF 73M |
|---|
| FY20 | CHF 15.4M | −CHF 61.9M |
|---|
| FY19 | CHF 110.5M | CHF 45.4M |
|---|
| FY18 | CHF 6.9M | −CHF 51M |
|---|
| FY17 | CHF 20.3M | −CHF 26.4M |
|---|
| FY16 | CHF 23.2M | −CHF 7.1M |
|---|
| FY15 | CHF 39.1M | CHF 20.3M |
|---|
| FY14 | - | - |
|---|
MarginsShare of revenue- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|
| FY25 | −1940.1% | −1971.6% |
|---|
| FY24 | −191.8% | −186.4% |
|---|
| FY23 | −362.3% | −366.4% |
|---|
| FY22 | −1800.4% | −1798% |
|---|
| FY21 | - | - |
|---|
| FY20 | −397% | −401.3% |
|---|
| FY19 | 40.3% | 41.1% |
|---|
| FY18 | −716.9% | −737.1% |
|---|
| FY17 | −111.3% | −130.4% |
|---|
| FY16 | −45% | −30.6% |
|---|
| FY15 | 47.6% | 51.9% |
|---|
| FY14 | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −CHF 70.2M |
|---|
| FY24 | CHF 65.3M |
|---|
| FY23 | −CHF 61.2M |
|---|
| FY22 | −CHF 74.8M |
|---|
| FY21 | −CHF 68.3M |
|---|
| FY20 | −CHF 61.2M |
|---|
| FY19 | CHF 53.3M |
|---|
| FY18 | −CHF 45.9M |
|---|
| FY17 | −CHF 23.9M |
|---|
| FY16 | −CHF 6.5M |
|---|
| FY15 | CHF 43.8M |
|---|
| FY14 | - |
|---|
Returned to shareholdersDividends paid and shares bought backShow the numbers
| Year | Buybacks |
|---|
| FY25 | - |
|---|
| FY24 | - |
|---|
| FY23 | - |
|---|
| FY22 | CHF 0 |
|---|
| FY21 | CHF 0 |
|---|
| FY20 | CHF 100K |
|---|
| FY19 | CHF 0 |
|---|
| FY18 | CHF 0 |
|---|
| FY17 | - |
|---|
| FY16 | - |
|---|
| FY15 | - |
|---|
| FY14 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- AC Immune
- Healthcare median
Show the numbers
| Year | AC Immune | Healthcare median |
|---|
| FY25 | −1971.6% | −30.6% |
|---|
| FY24 | −186.4% | −47% |
|---|
| FY23 | −366.4% | −58% |
|---|
| FY22 | −1798% | −80.4% |
|---|
| FY21 | - | −71.9% |
|---|
| FY20 | −401.3% | −62.2% |
|---|
| FY19 | 41.1% | −46.3% |
|---|
| FY18 | −737.1% | −49.6% |
|---|
| FY17 | −130.4% | −45.9% |
|---|
| FY16 | −30.6% | −36% |
|---|
| FY15 | 51.9% | −38.4% |
|---|
| FY14 | - | −35.5% |
|---|